Oreocnide integrifolia (Gaud.)Miq. exhibits hypoglycemic and hypolipidemic potentials on streptozotocin diabetic rats

dc.contributor.authorAnsarullah
dc.contributor.authorDevkar, Ranjitsinh
dc.contributor.authorJadeja, Ravirajsinh
dc.contributor.authorRamachandran, A. V.
dc.contributor.authorThounaojam, Menaka
dc.date.accessioned2009-07-08T07:20:38Z
dc.date.available2009-07-08T07:20:38Z
dc.date.issued2009-07-08T07:20:38Z
dc.description.abstractOreocnide integrifolia (Gaud.)Miq (Urticaceae) leaves are used to alleviate diabetic symptoms in folk medicine in northeast India. In the present study, dose and duration dependent hypoglycemic potentials were evaluated in streptozotocin induced diabetic rats. Administration of aqueous leaf extract (100, 250, 500 and 750 mg/kg body weight orally once daily) to diabetic rats reduced glycemic levels by 56 % by 4 weeks of treatment and was comparable to standard reference drug Metformin. The experimental data also revealed significant improvement in lowering lipid profile, Urea, Creatinine, Hb, HbA1c and insulin levels. The present study clearly demonstrates hypoglycemic and hypolipidemic potential of Oreocnide integrifolia leaf extract.en
dc.identifier.urihttp://hdl.handle.net/2003/26218
dc.identifier.urihttp://dx.doi.org/10.17877/DE290R-689
dc.language.isoen
dc.relation.ispartofseriesEXCLI Journal ; Vol. 8, 2009en
dc.subjectinsulinen
dc.subjectOreocnide integrifoliaen
dc.subjectstreptozotocinen
dc.subject.ddc610
dc.titleOreocnide integrifolia (Gaud.)Miq. exhibits hypoglycemic and hypolipidemic potentials on streptozotocin diabetic ratsen
dc.title.alternativea preliminary dose and duration dependent studyen
dc.typeText
dc.type.publicationtypearticle
dcterms.accessRightsopen access
eldorado.dnb.zdberstkatid2132560-1

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Oreocnide_060509_proof.pdf
Size:
150.88 KB
Format:
Adobe Portable Document Format
Description:
DNB
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.02 KB
Format:
Item-specific license agreed upon to submission
Description: